The global Aprepitant API market was valued at US$ 389 million in 2023 and is anticipated to reach US$ 530 million by 2030, witnessing a CAGR of 4.5% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Aprepitant API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Aprepitant API.
Report Scope
The Aprepitant API market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Aprepitant API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Aprepitant API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
JUBILANT GENERICS LTD
PIRAMAL PHARMA LTD
MSN LABORATORIES PRIVATE LTD
HETERO DRUGS LTD
DR REDDYS LABORATORIES LTD
GLENMARK LIFE SCIENCES LTD
INKE SA
WISDOM PHARMACEUTICAL CO LTD
VIWIT PHARMACEUTICAL CO LTD
NAVINTA LLC
PHARMATHEN SA
SCINOPHARM TAIWAN LTD
AUROBINDO PHARMA LTD
WOCKHARDT BIO AG
SOLARA ACTIVE PHARMA SCIENCES LTD
OLON SPA
SHANDONG ANXIN PHARMACEUTICAL CO LTD
LIANYUNGANG RUNZHONG PHARMACEUTICAL CO LTD
Segment by Type
±Ê³Ü°ù¾±³Ù²â≥99%
Purity<99%
Segment by Application
Injection
Capsule
Emulsion
Oral Suspension
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Aprepitant API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Aprepitant API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Aprepitant API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Aprepitant API Market Overview
1.1 Product Definition
1.2 Aprepitant API Segment by Type
1.2.1 Global Aprepitant API Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 ±Ê³Ü°ù¾±³Ù²â≥99%
1.2.3 Purity<99%
1.3 Aprepitant API Segment by Application
1.3.1 Global Aprepitant API Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Injection
1.3.3 Capsule
1.3.4 Emulsion
1.3.5 Oral Suspension
1.4 Global Market Growth Prospects
1.4.1 Global Aprepitant API Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Aprepitant API Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Aprepitant API Production Estimates and Forecasts (2019-2030)
1.4.4 Global Aprepitant API Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Aprepitant API Production Market Share by Manufacturers (2019-2024)
2.2 Global Aprepitant API Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Aprepitant API, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Aprepitant API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Aprepitant API Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Aprepitant API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Aprepitant API, Product Offered and Application
2.8 Global Key Manufacturers of Aprepitant API, Date of Enter into This Industry
2.9 Aprepitant API Market Competitive Situation and Trends
2.9.1 Aprepitant API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Aprepitant API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Aprepitant API Production by Region
3.1 Global Aprepitant API Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Aprepitant API Production Value by Region (2019-2030)
3.2.1 Global Aprepitant API Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Aprepitant API by Region (2025-2030)
3.3 Global Aprepitant API Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Aprepitant API Production by Region (2019-2030)
3.4.1 Global Aprepitant API Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Aprepitant API by Region (2025-2030)
3.5 Global Aprepitant API Market Price Analysis by Region (2019-2024)
3.6 Global Aprepitant API Production and Value, Year-over-Year Growth
3.6.1 North America Aprepitant API Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Aprepitant API Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Aprepitant API Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Aprepitant API Production Value Estimates and Forecasts (2019-2030)
4 Aprepitant API Consumption by Region
4.1 Global Aprepitant API Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Aprepitant API Consumption by Region (2019-2030)
4.2.1 Global Aprepitant API Consumption by Region (2019-2024)
4.2.2 Global Aprepitant API Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Aprepitant API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Aprepitant API Consumption by Country (2019-2030)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Aprepitant API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Aprepitant API Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Aprepitant API Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Aprepitant API Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Aprepitant API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Aprepitant API Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Aprepitant API Production by Type (2019-2030)
5.1.1 Global Aprepitant API Production by Type (2019-2024)
5.1.2 Global Aprepitant API Production by Type (2025-2030)
5.1.3 Global Aprepitant API Production Market Share by Type (2019-2030)
5.2 Global Aprepitant API Production Value by Type (2019-2030)
5.2.1 Global Aprepitant API Production Value by Type (2019-2024)
5.2.2 Global Aprepitant API Production Value by Type (2025-2030)
5.2.3 Global Aprepitant API Production Value Market Share by Type (2019-2030)
5.3 Global Aprepitant API Price by Type (2019-2030)
6 Segment by Application
6.1 Global Aprepitant API Production by Application (2019-2030)
6.1.1 Global Aprepitant API Production by Application (2019-2024)
6.1.2 Global Aprepitant API Production by Application (2025-2030)
6.1.3 Global Aprepitant API Production Market Share by Application (2019-2030)
6.2 Global Aprepitant API Production Value by Application (2019-2030)
6.2.1 Global Aprepitant API Production Value by Application (2019-2024)
6.2.2 Global Aprepitant API Production Value by Application (2025-2030)
6.2.3 Global Aprepitant API Production Value Market Share by Application (2019-2030)
6.3 Global Aprepitant API Price by Application (2019-2030)
7 Key Companies Profiled
7.1 JUBILANT GENERICS LTD
7.1.1 JUBILANT GENERICS LTD Aprepitant API Corporation Information
7.1.2 JUBILANT GENERICS LTD Aprepitant API Product Portfolio
7.1.3 JUBILANT GENERICS LTD Aprepitant API Production, Value, Price and Gross Margin (2019-2024)
7.1.4 JUBILANT GENERICS LTD Main Business and Markets Served
7.1.5 JUBILANT GENERICS LTD Recent Developments/Updates
7.2 PIRAMAL PHARMA LTD
7.2.1 PIRAMAL PHARMA LTD Aprepitant API Corporation Information
7.2.2 PIRAMAL PHARMA LTD Aprepitant API Product Portfolio
7.2.3 PIRAMAL PHARMA LTD Aprepitant API Production, Value, Price and Gross Margin (2019-2024)
7.2.4 PIRAMAL PHARMA LTD Main Business and Markets Served
7.2.5 PIRAMAL PHARMA LTD Recent Developments/Updates
7.3 MSN LABORATORIES PRIVATE LTD
7.3.1 MSN LABORATORIES PRIVATE LTD Aprepitant API Corporation Information
7.3.2 MSN LABORATORIES PRIVATE LTD Aprepitant API Product Portfolio
7.3.3 MSN LABORATORIES PRIVATE LTD Aprepitant API Production, Value, Price and Gross Margin (2019-2024)
7.3.4 MSN LABORATORIES PRIVATE LTD Main Business and Markets Served
7.3.5 MSN LABORATORIES PRIVATE LTD Recent Developments/Updates
7.4 HETERO DRUGS LTD
7.4.1 HETERO DRUGS LTD Aprepitant API Corporation Information
7.4.2 HETERO DRUGS LTD Aprepitant API Product Portfolio
7.4.3 HETERO DRUGS LTD Aprepitant API Production, Value, Price and Gross Margin (2019-2024)
7.4.4 HETERO DRUGS LTD Main Business and Markets Served
7.4.5 HETERO DRUGS LTD Recent Developments/Updates
7.5 DR REDDYS LABORATORIES LTD
7.5.1 DR REDDYS LABORATORIES LTD Aprepitant API Corporation Information
7.5.2 DR REDDYS LABORATORIES LTD Aprepitant API Product Portfolio
7.5.3 DR REDDYS LABORATORIES LTD Aprepitant API Production, Value, Price and Gross Margin (2019-2024)
7.5.4 DR REDDYS LABORATORIES LTD Main Business and Markets Served
7.5.5 DR REDDYS LABORATORIES LTD Recent Developments/Updates
7.6 GLENMARK LIFE SCIENCES LTD
7.6.1 GLENMARK LIFE SCIENCES LTD Aprepitant API Corporation Information
7.6.2 GLENMARK LIFE SCIENCES LTD Aprepitant API Product Portfolio
7.6.3 GLENMARK LIFE SCIENCES LTD Aprepitant API Production, Value, Price and Gross Margin (2019-2024)
7.6.4 GLENMARK LIFE SCIENCES LTD Main Business and Markets Served
7.6.5 GLENMARK LIFE SCIENCES LTD Recent Developments/Updates
7.7 INKE SA
7.7.1 INKE SA Aprepitant API Corporation Information
7.7.2 INKE SA Aprepitant API Product Portfolio
7.7.3 INKE SA Aprepitant API Production, Value, Price and Gross Margin (2019-2024)
7.7.4 INKE SA Main Business and Markets Served
7.7.5 INKE SA Recent Developments/Updates
7.8 WISDOM PHARMACEUTICAL CO LTD
7.8.1 WISDOM PHARMACEUTICAL CO LTD Aprepitant API Corporation Information
7.8.2 WISDOM PHARMACEUTICAL CO LTD Aprepitant API Product Portfolio
7.8.3 WISDOM PHARMACEUTICAL CO LTD Aprepitant API Production, Value, Price and Gross Margin (2019-2024)
7.8.4 WISDOM PHARMACEUTICAL CO LTD Main Business and Markets Served
7.7.5 WISDOM PHARMACEUTICAL CO LTD Recent Developments/Updates
7.9 VIWIT PHARMACEUTICAL CO LTD
7.9.1 VIWIT PHARMACEUTICAL CO LTD Aprepitant API Corporation Information
7.9.2 VIWIT PHARMACEUTICAL CO LTD Aprepitant API Product Portfolio
7.9.3 VIWIT PHARMACEUTICAL CO LTD Aprepitant API Production, Value, Price and Gross Margin (2019-2024)
7.9.4 VIWIT PHARMACEUTICAL CO LTD Main Business and Markets Served
7.9.5 VIWIT PHARMACEUTICAL CO LTD Recent Developments/Updates
7.10 NAVINTA LLC
7.10.1 NAVINTA LLC Aprepitant API Corporation Information
7.10.2 NAVINTA LLC Aprepitant API Product Portfolio
7.10.3 NAVINTA LLC Aprepitant API Production, Value, Price and Gross Margin (2019-2024)
7.10.4 NAVINTA LLC Main Business and Markets Served
7.10.5 NAVINTA LLC Recent Developments/Updates
7.11 PHARMATHEN SA
7.11.1 PHARMATHEN SA Aprepitant API Corporation Information
7.11.2 PHARMATHEN SA Aprepitant API Product Portfolio
7.11.3 PHARMATHEN SA Aprepitant API Production, Value, Price and Gross Margin (2019-2024)
7.11.4 PHARMATHEN SA Main Business and Markets Served
7.11.5 PHARMATHEN SA Recent Developments/Updates
7.12 SCINOPHARM TAIWAN LTD
7.12.1 SCINOPHARM TAIWAN LTD Aprepitant API Corporation Information
7.12.2 SCINOPHARM TAIWAN LTD Aprepitant API Product Portfolio
7.12.3 SCINOPHARM TAIWAN LTD Aprepitant API Production, Value, Price and Gross Margin (2019-2024)
7.12.4 SCINOPHARM TAIWAN LTD Main Business and Markets Served
7.12.5 SCINOPHARM TAIWAN LTD Recent Developments/Updates
7.13 AUROBINDO PHARMA LTD
7.13.1 AUROBINDO PHARMA LTD Aprepitant API Corporation Information
7.13.2 AUROBINDO PHARMA LTD Aprepitant API Product Portfolio
7.13.3 AUROBINDO PHARMA LTD Aprepitant API Production, Value, Price and Gross Margin (2019-2024)
7.13.4 AUROBINDO PHARMA LTD Main Business and Markets Served
7.13.5 AUROBINDO PHARMA LTD Recent Developments/Updates
7.14 WOCKHARDT BIO AG
7.14.1 WOCKHARDT BIO AG Aprepitant API Corporation Information
7.14.2 WOCKHARDT BIO AG Aprepitant API Product Portfolio
7.14.3 WOCKHARDT BIO AG Aprepitant API Production, Value, Price and Gross Margin (2019-2024)
7.14.4 WOCKHARDT BIO AG Main Business and Markets Served
7.14.5 WOCKHARDT BIO AG Recent Developments/Updates
7.15 SOLARA ACTIVE PHARMA SCIENCES LTD
7.15.1 SOLARA ACTIVE PHARMA SCIENCES LTD Aprepitant API Corporation Information
7.15.2 SOLARA ACTIVE PHARMA SCIENCES LTD Aprepitant API Product Portfolio
7.15.3 SOLARA ACTIVE PHARMA SCIENCES LTD Aprepitant API Production, Value, Price and Gross Margin (2019-2024)
7.15.4 SOLARA ACTIVE PHARMA SCIENCES LTD Main Business and Markets Served
7.15.5 SOLARA ACTIVE PHARMA SCIENCES LTD Recent Developments/Updates
7.16 OLON SPA
7.16.1 OLON SPA Aprepitant API Corporation Information
7.16.2 OLON SPA Aprepitant API Product Portfolio
7.16.3 OLON SPA Aprepitant API Production, Value, Price and Gross Margin (2019-2024)
7.16.4 OLON SPA Main Business and Markets Served
7.16.5 OLON SPA Recent Developments/Updates
7.17 SHANDONG ANXIN PHARMACEUTICAL CO LTD
7.17.1 SHANDONG ANXIN PHARMACEUTICAL CO LTD Aprepitant API Corporation Information
7.17.2 SHANDONG ANXIN PHARMACEUTICAL CO LTD Aprepitant API Product Portfolio
7.17.3 SHANDONG ANXIN PHARMACEUTICAL CO LTD Aprepitant API Production, Value, Price and Gross Margin (2019-2024)
7.17.4 SHANDONG ANXIN PHARMACEUTICAL CO LTD Main Business and Markets Served
7.17.5 SHANDONG ANXIN PHARMACEUTICAL CO LTD Recent Developments/Updates
7.18 LIANYUNGANG RUNZHONG PHARMACEUTICAL CO LTD
7.18.1 LIANYUNGANG RUNZHONG PHARMACEUTICAL CO LTD Aprepitant API Corporation Information
7.18.2 LIANYUNGANG RUNZHONG PHARMACEUTICAL CO LTD Aprepitant API Product Portfolio
7.18.3 LIANYUNGANG RUNZHONG PHARMACEUTICAL CO LTD Aprepitant API Production, Value, Price and Gross Margin (2019-2024)
7.18.4 LIANYUNGANG RUNZHONG PHARMACEUTICAL CO LTD Main Business and Markets Served
7.18.5 LIANYUNGANG RUNZHONG PHARMACEUTICAL CO LTD Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Aprepitant API Industry Chain Analysis
8.2 Aprepitant API Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Aprepitant API Production Mode & Process
8.4 Aprepitant API Sales and Marketing
8.4.1 Aprepitant API Sales Channels
8.4.2 Aprepitant API Distributors
8.5 Aprepitant API Customers
9 Aprepitant API Market Dynamics
9.1 Aprepitant API Industry Trends
9.2 Aprepitant API Market Drivers
9.3 Aprepitant API Market Challenges
9.4 Aprepitant API Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
JUBILANT GENERICS LTD
PIRAMAL PHARMA LTD
MSN LABORATORIES PRIVATE LTD
HETERO DRUGS LTD
DR REDDYS LABORATORIES LTD
GLENMARK LIFE SCIENCES LTD
INKE SA
WISDOM PHARMACEUTICAL CO LTD
VIWIT PHARMACEUTICAL CO LTD
NAVINTA LLC
PHARMATHEN SA
SCINOPHARM TAIWAN LTD
AUROBINDO PHARMA LTD
WOCKHARDT BIO AG
SOLARA ACTIVE PHARMA SCIENCES LTD
OLON SPA
SHANDONG ANXIN PHARMACEUTICAL CO LTD
LIANYUNGANG RUNZHONG PHARMACEUTICAL CO LTD
Ìý
Ìý
*If Applicable.
